Tyrosine Kinase Inhibitors Compared with Cytokine Therapy for Metastatic Renal Cell Carcinoma: Overview of Recent Clinical Trials Differentiating Clinical Response and Adverse Effects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tyrosine Kinase Inhibitors Compared with Cytokine Therapy for Metastatic Renal Cell Carcinoma: Overview of Recent Clinical Trials Differentiating Clinical Response and Adverse Effects

Published:2006-12 Issue: Volume:5 Page:S19-S23
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Dreicer Robert

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference24 articles.

1. Metastatic renal cancer treated with interleukin-2 and lymphokine-activated killer cells. A phase II clinical trial;Fisher;Ann Intern Med,1988

2. Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma;Atkins;Clin Can Res,2004

3. Interferon-a and survival in metastatic renal carcinoma. Early results of a randomised controlled trial;Collaborators;Lancet,1999

4. Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer;Pyrhonen;J Clin Oncol,1999

5. Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma;Negrier;N Engl J Med,1998

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy;Biomedicine & Pharmacotherapy;2019-07

2. Intérêt des anti-angiogéniques dans le cancer du rein localement avancé et métastatique en situation néo-adjuvante : à propos de 2 cas;Progrès en Urologie;2008-07

3. Traitement anti-angiogénique et cancer du rein : essais en cours et perspectives d’avenir;Progrès en Urologie;2008-07

4. Les anti-angiogéniques : de nouveaux standards thérapeutiques dans le cancer du rein métastatique;Progrès en Urologie;2008-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3